CardioMech AS said today that it has raised another $5 million in a heavily oversubscribed convertible note funding round, bringing its total raised during 2019 to $7.5 million. Experienced medtech investors participated in the round, whose proceeds will be used to further accelerate the development of its transcatheter mitral valve technology, according to the early-stage […]
Nevro taps ex-Thoratec CEO Grossman | Personnel Moves, March 20, 2019
Nevro Corp. (NYSE:NVRO) said yesterday that it named former Thoratec CEO Keith Grossman to replace president & CEO Rami Elghandour after striking a deal with one of its investors, Broadfin Capital. Grossman re-joined Thoratec after taking over at Conceptus in December 2011 and leading it to a $1.1 billion sale to Bayer in June 2013 (he’d […]
Transcatheter mitral valve tech dev CardioMech AS raises $3m
Early stage cardiovascular intervention tech developer CardioMech AS said today that it raised $2.5 million in a convertible note financing round. The Oslo-based company said that the round was significantly oversubscribed, and included investments from experienced angel investors. CardioMech is developing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the […]
CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018
CardioMech taps medtech veteran Nehm for CEO Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately. Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president […]
